Siemens Healthineers AG (SHL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Siemens Healthineers AG (SHL) has a cash flow conversion efficiency ratio of 0.027x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€492.00 Million ≈ $575.20 Million USD) by net assets (€18.48 Billion ≈ $21.61 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Siemens Healthineers AG to measure how many days the company can operate on defensive assets alone.
Siemens Healthineers AG - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Siemens Healthineers AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Siemens Healthineers AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Siemens Healthineers AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Skandinaviska Enskilda Banken AB (publ)
ST:SEB-A
|
0.151x |
|
Chaozhou Three-circle Group Co Ltd
SHE:300408
|
0.041x |
|
JD.com Inc.
F:013C
|
-0.026x |
|
DEUTSCHE BOERSE ADR 1/10
F:63DA
|
N/A |
|
UTD OV. BK-LOC-ADR/1 SD 1
F:UOB0
|
N/A |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
0.057x |
|
Ventas Inc
NYSE:VTR
|
0.040x |
|
ITC Limited
NSE:ITC
|
0.086x |
Annual Cash Flow Conversion Efficiency for Siemens Healthineers AG (2017–2024)
The table below shows the annual cash flow conversion efficiency of Siemens Healthineers AG from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see SHL market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-09-30 | €18.25 Billion ≈ $21.33 Billion |
€2.83 Billion ≈ $3.30 Billion |
0.155x | +32.52% |
| 2023-09-30 | €18.13 Billion ≈ $21.20 Billion |
€2.12 Billion ≈ $2.48 Billion |
0.117x | -7.35% |
| 2022-09-30 | €19.85 Billion ≈ $23.21 Billion |
€2.50 Billion ≈ $2.93 Billion |
0.126x | -29.73% |
| 2021-09-30 | €16.34 Billion ≈ $19.10 Billion |
€2.93 Billion ≈ $3.43 Billion |
0.180x | +16.49% |
| 2020-09-30 | €12.51 Billion ≈ $14.63 Billion |
€1.93 Billion ≈ $2.25 Billion |
0.154x | -6.77% |
| 2019-09-30 | €9.78 Billion ≈ $11.44 Billion |
€1.62 Billion ≈ $1.89 Billion |
0.165x | -10.08% |
| 2018-09-30 | €8.68 Billion ≈ $10.14 Billion |
€1.59 Billion ≈ $1.86 Billion |
0.184x | -69.82% |
| 2017-09-30 | €3.24 Billion ≈ $3.79 Billion |
€1.98 Billion ≈ $2.31 Billion |
0.609x | -- |
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment… Read more